E2F1 and lung carcinoma: Functional in vitro and in vivo assays indicated that miR-493 inhibited lung cancer cell proliferation, invasion and metastasis by directly targeting the 3′-UTR of E2F1 to elicit a specific and robust knockdown of the protein.